Five Contract Clauses Every Cosmetic Manufacturer Must Nail (Before Their Next Client Does)

Setting the stage

Whether you’re a contract manufacturer scaling K-beauty dupes or a boutique lab whipping up CBD serums, your manufacturing agreement is the single document that determines whether a client relationship is profitable or ruinous. Most cosmetic manufacturers spend months perfecting their formulas and about 20 minutes reading the contract that governs who owns them.

That’s a dangerous gap.

After reviewing hundreds of manufacturing agreements for beauty and cosmetics businesses, there are five clauses that consistently show up as either poorly written, missing entirely, or subtly tilted against the manufacturer. Getting these right before you sign (or before your client does) is the difference between a scalable business and one that bleeds legal fees.

Here’s what to look for.

---

1. Scope of Services — “The Formula Freeze”

Why it matters: Without a precise scope of services clause, a brand can come back months after launch demanding reformulations, fragrance tweaks, or texture changes — and expect you to absorb the cost. Manufacturers get caught in an endless loop of “just one more change” that eats into margin and delays production for other clients.

A Formula Freeze clause locks the product specification at signing. Any change — no matter how small — requires a written change order, a revised timeline, and updated pricing. This isn’t being difficult; it’s basic business hygiene that protects both parties from scope creep.

Language to keep: “Any modification to the Product Formula must be requested in writing and accepted by Supplier pursuant to a signed Change Order, which shall include revised pricing and delivery terms.”

Delete vague phrases like “including any improvements made by Supplier” — they turn your R&D roadmap into an unfunded liability and can even cloud IP ownership down the line.

---

2. Price Escalation & Raw‑Material Shocks

Why it matters: Raw material costs in the cosmetics industry can swing dramatically based on supply chain disruptions, commodity price changes, and regulatory shifts. A contract that locks you into a fixed price for 12-24 months with no adjustment mechanism can turn a profitable run into a loss by month six.

Tie your bill-of-materials costs to a public index such as the ICIS Chemical Price Index with a ±10% collar and a quarterly true-up clause. This gives you a predictable mechanism for passing through cost increases without renegotiating from scratch every quarter.

Also include a raw-material availability carve-out: if a key ingredient becomes unavailable or is subject to regulatory action (hello, MoCRA ingredient reviews), you need the right to substitute with prior written notice rather than being in breach of contract. Brands that don’t understand supply chains will push back on this — hold firm, because it protects them too.

---

3. MoCRA Compliance Allocation

Why it matters: Since the Modernization of Cosmetics Regulation Act (MoCRA) took effect, there’s been a scramble over who bears the burden of FDA compliance obligations — facility registration, product listings, adverse event reporting, and upcoming Good Manufacturing Practice (GMP) requirements.

Brands often try to push all of this onto manufacturers. Don’t accept that framing. Under MoCRA, the “Responsible Person” — typically the brand or the entity whose name appears on the label — carries the primary compliance obligation. Your contract should reflect that.

Language to include: “Buyer shall serve as ‘Responsible Person’ under MoCRA and shall maintain product listings, adverse-event records, and facility registrations as required by 21 U.S.C. § 364 et seq. Supplier shall cooperate with reasonable documentation requests at no additional cost, provided such requests do not exceed [X] hours per quarter.”

Setting a cooperation cap protects you from becoming a de facto compliance department for underfunded brands.

---

4. Intellectual‑Property Ownership

Why it matters: Intellectual property ownership in a manufacturing relationship can get complicated fast. The brand assumes they own everything. You assume you retain your trade secrets, proprietary blending methods, and base formulas. Neither assumption is legally valid without clear contract language.

There are two clean approaches:

Option A (most common): Buyer owns the finished formula specific to their product. Supplier retains all background IP, proprietary methods, base formulations, and manufacturing processes. Supplier grants Buyer an exclusive license to use the finished formula — but only for that specific product and label.

Option B (for custom development work): If Supplier is creating something truly novel, negotiate a development fee plus a royalty on units produced, with IP reverting to Supplier if Buyer discontinues the product.

The red line: never agree to language that assigns “all derivative works” or “improvements” to the buyer without strict definitions. That clause can inadvertently transfer your core know-how.

---

5. Indemnity & Recall Matrix

Why it matters: Product recalls in the cosmetics industry are increasingly common as MoCRA enforcement ramps up, and a recall without a clearly defined indemnity matrix turns into a finger-pointing exercise that benefits no one — except the attorneys billing by the hour.

Build a fault-tier chart directly into the contract so there’s no ambiguity about who pays when something goes wrong:

Trigger	Who pays?
GMP deviation proven	Supplier
Buyer‑supplied artwork misbranding	Buyer
Force‑majeure raw‑material contamination	Split 50/50, capped at COGS for affected batch

Beyond the table, every indemnity clause needs a liability cap tied to real numbers — not feelings. A cap of 100% of the fees paid in the prior 12 months is a reasonable standard starting position for manufacturers. Brands will push for uncapped liability; hold firm on the cap and offer robust insurance certificates instead.

Also carve out fraud and gross negligence from the cap — you don’t want those protections, and a court would likely void them anyway.

---

Frequently Asked Questions

Do I need a new contract for every cosmetic client? Not necessarily — a well-drafted Master Services Agreement (MSA) paired with product-specific Statements of Work is the most efficient structure. The MSA governs the relationship; the SOW governs each product run.

What happens if my client won’t negotiate these clauses? That itself is useful information. A client unwilling to agree to reasonable IP ownership and recall allocation terms is a client likely to become a legal problem. Use the negotiation as a vetting process.

How often should I update my manufacturing contracts? At minimum annually, and any time there’s a major regulatory change — MoCRA’s GMP deadline in December 2026 is a good trigger for a full contract audit right now.

Can I use a template for cosmetic manufacturing agreements? Templates are a starting point, not a finish line. The cosmetics industry has enough regulatory nuance — MoCRA, FDA labeling, state-specific requirements — that a template should always be reviewed by counsel familiar with beauty industry law before you rely on it.

---

Implementation playbook

1. Audit existing MSAs — mark expiration and auto‑renewal dates.
   
2. Roll out a “Clause Library” for sales to paste into every deal.
   
3. Train PMs to recognize scope‑creep requests and route them to change‑orders.
   
4. Schedule annual contract health checks — align with your ISO 9001 internal audit.
   

CLS pro tip: During price‑increase season, send clients a “GMP & Regulatory Addendum” that folds in MoCRA language and updated IP terms. Clients perceive added value, making the cost bump easier to accept.

---

Ready to bulletproof your contracts before Q3 quote season?

Book a 30‑minute Contract‑Strategy Session.